Cabaletta Bio Inc (CABA)
12.61
-0.26
(-2.02%)
USD |
NASDAQ |
May 07, 10:40
Cabaletta Bio 1 Year Total Returns (Daily): 2.31% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 06, 2024 | 2.31% |
| May 03, 2024 | 1.23% |
| May 02, 2024 | 8.81% |
| May 01, 2024 | 8.86% |
| April 30, 2024 | 2.55% |
| April 29, 2024 | 0.96% |
| April 26, 2024 | 32.97% |
| April 25, 2024 | 50.74% |
| April 24, 2024 | 50.87% |
| April 23, 2024 | 55.06% |
| April 22, 2024 | 55.06% |
| April 19, 2024 | 55.12% |
| April 18, 2024 | 64.55% |
| April 17, 2024 | 77.40% |
| April 16, 2024 | 108.6% |
| April 15, 2024 | 107.2% |
| April 12, 2024 | 110.8% |
| April 11, 2024 | 114.5% |
| April 10, 2024 | 119.4% |
| April 09, 2024 | 139.4% |
| April 08, 2024 | 129.5% |
| April 05, 2024 | 122.0% |
| April 04, 2024 | 100.1% |
| April 03, 2024 | 94.56% |
| April 02, 2024 | 99.40% |
| Date | Value |
|---|---|
| April 01, 2024 | 103.4% |
| March 28, 2024 | 126.3% |
| March 27, 2024 | 127.8% |
| March 26, 2024 | 125.2% |
| March 25, 2024 | 123.0% |
| March 22, 2024 | 131.6% |
| March 21, 2024 | 126.9% |
| March 20, 2024 | 137.2% |
| March 19, 2024 | 122.2% |
| March 18, 2024 | 122.0% |
| March 15, 2024 | 152.9% |
| March 14, 2024 | 138.5% |
| March 13, 2024 | 175.0% |
| March 12, 2024 | 192.5% |
| March 11, 2024 | 187.9% |
| March 08, 2024 | 151.6% |
| March 07, 2024 | 151.9% |
| March 06, 2024 | 150.1% |
| March 05, 2024 | 138.2% |
| March 04, 2024 | 141.4% |
| March 01, 2024 | 187.4% |
| February 29, 2024 | 158.8% |
| February 28, 2024 | 160.7% |
| February 27, 2024 | 174.8% |
| February 26, 2024 | 186.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-94.97%
Minimum
Sep 23 2022
2.41K%
Maximum
Sep 22 2023
194.6%
Average
12.19%
Median
Oct 25 2021
1 Year Total Returns (Daily) Benchmarks
| Editas Medicine Inc | -41.97% |
| Regeneron Pharmaceuticals Inc | 25.79% |
| Vertex Pharmaceuticals Inc | 15.63% |
| FibroGen Inc | -93.34% |
| Deciphera Pharmaceuticals Inc | 87.65% |